Part II: New candidates of pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors.
Galal SA, Khairat SHM, Ali HI, Shouman SA, Attia YM, Ali MM, Mahmoud AE, Abdel-Halim AH, Fyiad AA, Tabll A, El-Shenawy R, El Abd YS, Ramdan R, El Diwani HI.
Galal SA, et al. Among authors: ali mm, ali hi.
Eur J Med Chem. 2018 Jan 20;144:859-873. doi: 10.1016/j.ejmech.2017.12.023. Epub 2017 Dec 8.
Eur J Med Chem. 2018.
PMID: 29316526